COVID 19 PANDEMIC: Prostate Cancer Diagnosis and Therapy Market 2020 – Industry Growth, Comprehensive Analysis, Trends, Values, Key Factors and Forecast 2025

Global Prostate Cancer Diagnosis and Therapy Market: Information by Type (Prostatic Adenocarcinoma, Small Cell Carcinoma and others), By Component (Therapy and Diagnosis), By End User (Specialty Centers, Hospitals & Clinics and others) and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2025

To Learn More About The Global Trends Impacting The Future Of Market Research, Download A Free Sample:

https://www.marketresearchfuture.com/sample_request/1580

Market Highlights

Global Prostate Cancer Diagnosis and Therapy Market is expected to register a CAGR of 5.10% during the forecast period, with a market value of USD 18,417.72 Million by 2025.

Prostate cancer is one of the most commonly occurring cancers in men above 55 years of age. More than 80% of the male population are suffering from either one of the prostate cancers (prostatic adenocarcinoma, sarcomas, transitional cell carcinoma, and squamous cell carcinoma) across the globe.

Segment Analysis

The Global Prostate Cancer Diagnosis and Therapy Market is segmented into type, component, and end-user. By type, the market has been segmented into prostatic adenocarcinoma, small cell carcinoma, and others. Based on the product, the market has been segmented into reagents, analyzers, and consumables. Based on the components, the global prostate cancer diagnosis and therapy market has been categorized as therapy and diagnosis. The therapy segment is further is sub-segmented into hormonal therapy, chemotherapy, radiotherapy drugs, and immunotherapy. Hormonal therapy is segmented into anti-androgens, LHRH analogs, and LHRH antagonists. Chemotherapy is segmented into docetaxel, cabazitaxel, and others. The diagnosis is sub-segmented into diagnostic imaging, tissue biopsy, and others.

On the basis of end-user, the market has been segmented into specialty centers, hospitals & clinics, and others.

Regional Analysis

The Global Prostate Cancer Diagnosis and Therapy Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are expected to hold the largest share of the global prostate cancer diagnosis and therapy market owing to the increasing prevalence of prostate cancer and increasing FDA approvals for the treatment products to support the growth of the market. For instance, in December 2019, Astellas Pharma Inc. received FDA approval for supplemental New Drug Application (sNDA) for XTANDI (enzalutamide) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC). Hence, increasing product approvals in the region are expected to support regional market growth.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Prostate Cancer Diagnosis and Therapy Market— Dendreon Pharmaceuticals LLC (US), Abbvie Inc. (US), AstraZeneca (UK), Bayer AG (Germany), Sanofi (France), Ipsen Pharma (France), Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (US), Tolmar Pharmaceuticals, Inc.(US), and Ferring BV (Switzerland), among others.

Key Findings of the Study

The Global Prostate Cancer Diagnosis and Therapy Market was valued at USD 13,002.20 Million in 2018, is estimated to grow at USD 18,417.72 Million by 2025 at a CAGR of 5.1 % during the assessment period
Americas accounted for the largest share of the global market due to the high incidence rates of prostate cancer in the region and increasing awareness about procedures related to prostate cancer diagnosis and therapy in the US prompts market growth in this region
Based on types, the prostatic adenocarcinoma segment accounted for the largest market share in 2018
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/prostate-cancer-market-1580

Intended Audience

Medical Device Companies
Hospitals & Clinics
Pharmaceutical Companies
Academic institutes
More Healthcare Industry Related Reports

Population Health Management Market – Global Forecast till 2023

https://www.marketresearchfuture.com/reports/population-health-management-market-3123

Home Healthcare Market – Global Forecast till 2023

https://www.marketresearchfuture.com/reports/home-Healthcare-market-2030

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

This release was published on openPR.